WiseTech Global FY profit dips 11% on e2open expenses, restructuring costs
Source: Investing.com

WiseTech Global reported FY net profit of $178.7M, down 11% (EPS 53.6c, -11%) due to acquisition/integration costs and higher net finance costs of $131.7M after funding its ~$2.1B e2open purchase. Revenue surged 79% to $1.396B and underlying net profit rose 29% to $313.5M, while operating profit increased 21% to $353.3M as margins compressed (gross margin 77% vs 86%). Guidance for FY ending Jun 2027 calls for revenue of $1.48B–$1.54B (+6% to +10%) and underlying EBITDA of $725M–$780M (up 12% to 21%) with 49%–51% margin, suggesting a cautious earnings recovery as integration costs normalize.
Analysis
The market should focus less on the headline growth and more on the quality of that growth: the acquisition is inflating scale while simultaneously compressing gross margin and tying up capital in a higher-debt structure. That combination usually supports only a temporary multiple lift; over the next 1-3 months, the key question is whether management can prove operating leverage at the combined platform, or whether integration absorbs the incremental revenue and keeps free cash flow conversion below software peers.
Competitive dynamics likely tilt toward cleaner, higher-margin workflow software vendors such as DSGX and MANH. If WiseTech remains burdened by services-heavy revenue and elevated finance costs, customers and channel partners may prefer vendors with simpler economics, faster implementation, and less balance-sheet risk; that can matter in procurement cycles where CIOs want lower execution risk, not just feature breadth. The second-order effect is that a stretched integration agenda can slow product cadence in the core platform, which is where the real moat is tested.
The main catalyst path is the next two reporting cycles: management needs to show that the margin drag is transitory and that debt paydown is outrunning integration costs. If underlying EBITDA misses even modestly versus the new outlook, the stock is vulnerable to multiple compression because the market will re-rate it as a levered roll-up rather than a pure SaaS compounder. Conversely, the thesis is falsified if customer retention stays sub-1% while the company converts EBITDA into meaningful FCF and starts deleveraging faster than expected.
Contrarian view: the selloff may be partially overdone if investors are extrapolating the current mix shift too far into perpetuity. The core platform is still growing, and if integration stabilizes, the earnings power could re-accelerate in 6-18 months. But near term, the burden of proof is on management, and the asymmetry still looks better for owning cleaner peers than paying up for a levering integration story.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.12
Ticker Sentiment
Key Decisions for Investors
- Short WIGBY on strength into the next 2-4 weeks; thesis is multiple compression from lower gross margin and elevated net finance costs if the market stops treating the acquisition as purely accretive.
- Pair trade: long DSGX / short WIGBY for 1-3 months to express preference for higher-quality logistics software with less integration risk and cleaner cash conversion.
- If WIGBY is liquid enough, buy downside protection into the next earnings cycle rather than outright shorting; the key risk is a quick de-leveraging narrative that could squeeze the stock before margins normalize.
- Set a watch item on underlying EBITDA margin and net debt/EBITDA; if margin fails to hold near guidance or deleveraging stalls over the next two quarters, increase short exposure.
- Avoid adding after any post-earnings rally unless management provides verifiable FCF conversion and integration synergy milestones; without that, upside is likely tactical, not structural.
More News
- Why is T-Mobile stock tumbling today?
- Why is Verizon stock sliding today?
- SpaceX wants to become a 'major mobile carrier' with low-band spectrum acquisition
- OpenAI projected to bring in $20bn less in revenue than expected
- Soitec climbs 7% as BofA turns bullish on silicon photonics demand
- Schott Pharma drops after Deutsche Bank downgrades on demanding valuation
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Alternative Data Due Diligence for Institutional Investors
- Introducing AllMind: A New Data & AI Workspace for Institutional Investors